Pacira Pharma Stock Price (NASDAQ:PCRX)

Add to My Stocks
$38.05 $0.85 (2.28%) PCRX stock closing price Jun 19, 2018 (Closing)
Prev Close* : $37.2
Market Cap:
$1.52B
Day Low: $36.55
52 Week Low: $26.95
Open: $37.05
Volume: -
Day High: $38.15
52 Week High: $51.10
Dividend:
0.00

Latest Stock Market News

Latest Articles

Pacira Pharma News - From Partners

PCRX Stockcharts

View PCRX PE ratio, PS ratio stocks charts and compare with peers.
PCRX Chart
Note: Compare Pacira Pharma stock price history with the index and industry peers.

Pacira Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
5.31
PB ratio (
price to book ratio
)
5.72

Pacira Pharma Returns

ROE
(return on equity)
-12%

Pacira Pharma Financial Ratios

Asset Turnover
0.48
Receivables Turnover
10.07
Debt to Equity
1.01
Dividend Yield
0%

PCRX Industry Peers

Company Price Change (%)
Ptc Therapeutics (PTCT)33.2414.64 (30.58%)
Zogenix (ZGNX)47.550.4 (0.83%)
Cara Therapeutics (CARA)16.620.31 (1.83%)
Acelrx Pharma (ACRX)4.180.08 (1.95%)
Durect (DRRX)2.10.07 (3.23%)
Heron Therapeutics (HRTX)30.250.6 (2.02%)
Halyard Health (HYH)60.490.47 (0.77%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Neptune Tech. & Bio. (NEPT)3.230.78 (31.84%)
Galmed Pharma (GLMD)15.690.78 (5.23%)
Synergy Pharma (SGYP)1.890.08 (4.42%)
Achaogen (AKAO)12.210.5 (4.27%)
BioCryst Pharma (BCRX)5.970.2 (3.47%)
Portola Pharma (PTLA)42.771.36 (3.28%)
Endo International (ENDP)9.440.29 (3.17%)
Top gainers from Medical-Drugs industry
* As of Jun 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)33.2414.64 (30.58%)
CORREVIO PHARMA (CORV)3.680.22 (5.64%)
Corcept Therapeutics (CORT)16.2750.61 (3.61%)
Redhill Biopharma (RDHL)7.90.29 (3.54%)
AMNEAL PHARMACT (AMRX)18.840.69 (3.53%)
Nature's Sunshine Products (NATR)8.60.3 (3.37%)
Durect (DRRX)2.10.07 (3.23%)
Top losers from Medical-Drugs industry
* As of Jun 20, 2018

Pacira Pharmaceuticals Inc Stock News - Partner Headlines

Pacira Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues286.63M276.37M248.99M197.66M85.55M
Net Income-42.61M-37.94M1.85M-13.71M-63.9M
Total Operating Expense223.65M198.28M167.7M125.39M84.06M
View Pacira Pharma income statement
balance sheet20172016201520142013
Total Assets628.37M391.46M389.62M326.07M169.82M
Total Liabilities348.88M172.49M171.23M154.92M128.57M
Shareholders Equity279.48M218.97M218.39M171.14M41.24M
View Pacira Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-2.57M22.27M-22.34M-0.45M-4.41M
Net Cash from (used by) Operating Activities17.78M33.45M28.99M25.46M-43.21M
Increase (Decrease) in Prop Plant And Equipment-19.26M-24.7M-41.27M-21.88M-12.79M
View Pacira Pharma cash flow statement

Pacira Pharma Stock Message Board

Pacira Pharma stock gained 2.28%, and the last close price as of Jun 19, 2018 is $38.05 for PCRX stock. Looking at Pacira Pharma market capitalization, which currently stands at $1.52B, we can say that PCRX stock is a Small Cap stock. Pacira Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy PCRX stock than sell it, then Pacira Pharma stock price goes up. Conversely, if more investors wanted to sell PCRX stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Pacira Pharma stock quote data shows the number of shares traded. For Ex: 507,702 Pacira Pharma shares were traded as of last trading day, as seen from Pacira Pharma stock chart. Pacira Pharma paid 0.00 stock dividends to its shareholders during last quarter. One can observe stock price trends and check for volatility by checking Pacira Pharma stock price history.